Following an inducing signal of unknown type, and in a burst of activity, oligodendrocytes (OLGs) form myelin; thereafter, they maintain it. OLGs are capable or remyelinating central nervous system axons after a demyelinating injury, implying a capacity to respond a second time to a myelin-inducing signal. In preliminary studies we have found that cultured OLGs express a voltage- dependent outward current that has an inactivating/transient component and a non-inactivating or steady state component. In addition, these cells develop an inward rectifier current after a week in culture. The magnitude of these currents are modified with time/attachment in culture, as is myelin metabolism. The cultured OLG system offers the opportunity to investigate the relationship between the signal for myelin synthesis and ionic current modulation. We will use whole-cell and single channel techniques to identify and characterize further the ionic currents of OLGs investigating the relationship between ionic current modulation and myelin reformation. Studies of ion channels will be carried out on single cells as well as on isolated membrane patches in order to obtain a molecular picture of the mechanisms of ion channel involvement in demyelinating disease. The outward K+ current of OLGs are similar to the voltage-gated K+ currents that have been described for the T lymphocyte. Modulation of the electrical properties of both OLGs and lymphocytes may provide a mechanistic basis for the failure of remyelination and for the abnormalities of immune regulation observed in MS. We will characterize the effects of protein phosphorylation on whole-cell K+ currents using agents known to modulate myelin secretion in OLGs. We will study the sensitivity of the K+ currents to neuropeptides, neurotransmitters, lymphokines, interferons surface adhesion molecules, and purified fractions of MS CSF. We will examine whether these factors are capable of producing transient increases in (Ca++)i using the calcium sensitive dye Fura-2. We will characterize the electrophysiological changes that accompany the transformation of T cells as well as OLGs from the normal to the pathological state. We will study the difference in ionic current activation or expression in T cell lines from control as well as progressive MS patients.

Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Jensen, M A; Dayal, A; Arnason, B G (1999) Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis. J Autoimmun 12:73-80
Qu, Z X; Dayal, A; Jensen, M A et al. (1998) All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol 55:315-21
Chelmicka-Schorr, E; Wiegmann, K; Wollmann, R et al. (1998) Immunoaugmenting effect of FK 506 on experimental allergic encephalomyelitis in Lewis rats. J Autoimmun 11:329-34
Takeda, M; Soliven, B (1997) Arachidonic acid inhibits myelin basic protein phosphorylation in cultured oligodendrocytes. Glia 21:277-84
Arnason, B G; Toscas, A; Dayal, A et al. (1997) Role of interferons in demyelinating diseases. J Neural Transm Suppl 49:117-23
Attali, B; Wang, N; Kolot, A et al. (1997) Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells. J Neurosci 17:8234-45
Lee, T E; Philipson, L H; Nelson, D J (1996) N-type inactivation in the mammalian Shaker K+ channel Kv1.4. J Membr Biol 151:225-35
Pliskin, N H; Hamer, D P; Goldstein, D S et al. (1996) Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology 47:1463-8
Arnason, B G (1996) Interferon beta in multiple sclerosis. Clin Immunol Immunopathol 81:1-11
Jensen, M A; Arnason, B G; Toscas, A et al. (1996) Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis. J Autoimmun 9:587-97

Showing the most recent 10 out of 58 publications